Top Page
Auxly Cannabis Group
(TSX:XLY)
Auxly Cannabis Group (XLY) vs. iShares MSCI Canada ETF (EWC)
Auxly Cannabis Group Business Overview & Revenue Model
Auxly Cannabis Group Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 122.33M | 101.08M | 94.47M | 83.83M | 50.80M |
| Gross Profit | 59.93M | 21.28M | 17.92M | 19.29M | 11.14M |
| EBITDA | 24.38M | -10.82M | -93.40M | -13.64M | -57.18M |
| Net Income | -16.35M | -44.51M | -130.29M | -45.91M | -87.43M |
Balance Sheet | |||||
| Total Assets | 261.53M | 261.90M | 331.82M | 450.42M | 378.96M |
| Cash, Cash Equivalents and Short-Term Investments | 18.50M | 15.75M | 14.78M | 14.89M | 21.50M |
| Total Debt | 68.47M | 159.04M | 193.59M | 190.10M | 124.68M |
| Total Liabilities | 145.87M | 210.86M | 246.13M | 242.31M | 187.43M |
| Stockholders Equity | 115.66M | 51.05M | 90.41M | 212.52M | 195.94M |
Cash Flow | |||||
| Free Cash Flow | 14.02M | 6.61M | -11.67M | -50.01M | -53.86M |
| Operating Cash Flow | 16.78M | 8.21M | -2.48M | -49.63M | -33.13M |
| Investing Cash Flow | -445.00K | -1.56M | 1.18M | 17.33M | -14.53M |
| Financing Cash Flow | -13.59M | -5.68M | 1.18M | 26.40M | 24.74M |
Auxly Cannabis Group Technical Analysis
Auxly Cannabis Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $215.07M | 7.18 | 22.40% | ― | 27.24% | ― | |
51 Neutral | $7.81B | -0.22 | -40.01% | 2.29% | 21.48% | -2.11% | |
| ― | $221.50M | 117.61 | 1.86% | ― | ― | ― | |
| ― | $22.90M | ― | -19.58% | ― | ― | ― | |
| ― | $54.40M | 5.24 | 22.76% | ― | ― | ― | |
53 Neutral | C$163.88M | ― | -20.58% | ― | -1.42% | 35.15% | |
| ― | $23.92M | 15.05 | 6.23% | ― | ― | ― |
Auxly Cannabis Group Corporate Events
Auxly Cannabis Group reported a robust financial performance for the second quarter of 2025, with net revenues increasing by 33% year-over-year to $38.8 million and a significant increase in net income by 315% to $8.3 million. The company also improved its gross margin to 52% and achieved an adjusted EBITDA of $11.6 million, reflecting a 123% increase. The company has strengthened its balance sheet by amending senior debt and converting remaining debt into equity, which reduces interest expenses and supports long-term growth. Auxly’s market leadership is reinforced by its top-selling cannabis brands and products, and the company aims to continue leveraging its scale to deliver sustainable financial performance.
Auxly Cannabis Group Inc. announced it will release its second quarter and six-month financial results for 2025 on August 14, 2025. Notably, the company will not conduct an earnings conference call and does not plan to reinstate such calls until further notice, which may impact investor engagement and transparency.
Auxly Cannabis Group has successfully completed two significant financial transactions, including amending its credit facility with the Bank of Montreal and settling its debts with Imperial Brands. These moves have eliminated $21 million in debt, reduced annual debt service obligations by $700,000, and provided access to a new $10 million revolving facility, enhancing the company’s financial stability and growth potential.
Auxly Cannabis Group Inc. announced the results of its annual general meeting of shareholders, where all proposed matters were approved by the requisite majority. The meeting saw the election of directors and the re-appointment of Ernst & Young LLP as auditors, reflecting strong shareholder support and stability in the company’s governance.
Auxly Cannabis Group Inc. has announced two significant agreements aimed at strengthening its financial position. The company has entered into a non-binding agreement to amend its existing credit facility with the Bank of Montreal, which will enhance liquidity and provide flexibility for growth initiatives. Additionally, Auxly has reached an exchange agreement with Imperial Brands to settle over $21 million of debt through equity instruments, thereby improving its capital structure and financial stability.
Auxly Cannabis Group Inc. announced its Annual General Meeting of Shareholders will be held on June 30, 2025, in Toronto. Due to limited seating, shareholders must pre-register to attend in person, and an audio teleconference will be available for real-time listening, though voting must be done in advance.
Auxly Cannabis Group Inc. reported a strong financial performance for the first quarter of 2025, with a 29% increase in net revenues to $32.7 million and a 232% rise in adjusted EBITDA. The company maintained its position as a top player in the Canadian cannabis market, with its Back Forty brand achieving the number one spot in Canada. Auxly’s strategic focus on innovation and operational efficiency has resulted in significant growth, reinforcing its market leadership and setting a solid foundation for future expansion.
The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.